Skip to main content
. 2018 Oct 4;82(6):1021–1029. doi: 10.1007/s00280-018-3693-6

Table 2.

Best overall response (group A, full analysis set)

Number of patients with Responsea rate (95% confidence interval), % Disease controlb rate (95% confidence interval), %
CR PR SD PD NE
0 2 28 20 3 3.8 (0.5–13.0) 56.6 (42.3–70.2)

CR complete response, PR partial response, SD stable disease, PD progressive disease, NE not evaluable

aCR + PR

bCR + PR + SD